Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Blood flow monitoring system to reduce risks during heart surgery

03.11.2004


A unique haemodynamic (blood flow) monitoring system which will help to minimise the risk of complications during cardiovascular surgery is being developed by Leeds-based medical devices company, Medics Research Ltd.



Described as “the most significant breakthrough in measuring key cardiovascular parameters in over 30 years”, the HeartSmart® technology was presented to investors attending the White Rose BioScience Forum in York today (03 November).

Limitations and risks attaching to existing monitoring technologies mean that the majority of heart surgery patients are monitored for blood pressure only and not for other key cardiovascular variables, such as cardiac output, which provides vital information about the delivery of oxygen to the patient’s tissues and organs.


The standard method of assessing cardiac output is via the pulmonary artery catheter. This technology is over thirty years old and has key, potentially fatal risks associated with it, making its use restricted to only the most critically ill patients.

Based on over twenty years’ research by Medics Research founder, cardiovascular physiologist Ken Davies, HeartSmart® provides clinicians with information about a patient’s cardiovascular output prior to, during and following surgery.

The technology comprises software that will work in conjunction with existing hospital equipment. At its core is a set of unique analytically derived and clinically proven algorithms that define the relationship between all key blood flow variables. These combine to provide a mechanism for the continuous monitoring of cardiac output.

Outlining the development of HeartSmart®, Davies said: “The supply of this crucial information will minimise the risk of adverse events arising from surgery, and will play a significant role in speeding up recovery times and the length of time in hospital. HeartSmart® is the most advanced haemodynamic system in the world. It will save lives, it will save time and it will save money.”

Medics Research is seeking investment in the region of £750,000 to complete the commercialisation of its groundbreaking product. This is the first time that the White Rose Bioscience Forum has held an investment track. The track was run Connect Yorkshire, an organisation which specialises in providing training and mentoring to high tech companies in the region to help them achieve investment readiness.

Simon Browning, managing director of Connect Yorkshire said: “The HeartSmart® technology shows how a scientist can combine new technology and research to meet a crucial market need. Heart disease is something that has affected everyone in some way, and this innovative range of products could make an enormous difference to hundreds of thousands of people – not only the medical community and the patients themselves, but their relatives and friends too.”

Simon Donoghue, acting chief executive of the White Rose University Consortium said: “This session has demonstrated to delegates the wealth of novel bioscience research being undertaken in the region. We hope that this opportunity will result in further funding for the companies allowing their technologies to be developed further.”

Clare Elsley | alfa
Further information:
http://www.whiterose.ac.uk

More articles from Health and Medicine:

nachricht Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin

nachricht Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>